About 100 reports

  • SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)

Spinal cord stimulation involves the implantation of an implanted pulse generator (IPG) in the spinal cord to provide pain relief.

  • Neurological Disorder
  • North America
  • United States
  • Boston Scientific Corporation
  • Medtronic, Inc.

You can easily book an appointment w ith one online.

  • Neurological Disorder
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Koninklijke Philips N.V.
  • Medtronic, Inc.

Quell is available as over the counter for chronic pain relief.

  • Neurological Disorder
  • Urology Device
  • World
  • Market Size
  • Boston Scientific Corporation

If the opioid is ineffective in phase ##, the combinations of opioids with either clonidine or bupivacaine are used to give pain relief for individual with neuropathic pain.

  • Neurological Disorder
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • INCREASING FOCUS ON RESEARCH

These initiatives enable the efforts to increase awareness among various stakeholders regarding the growing disease burden as well as the technological advances for rapid muscular and pain relief.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sonova Holding AG
  • HIGH INCIDENCE RATES OF BRAIN ANEURYSM AND CEREBRAL DISORDERS

Currently, SCS systems are used for pain relief, but in the future, they will be also used to treat angina and asthma.

  • Neurological Disorder
  • World
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Stryker Corporation

Global pacemaker electrodes market 2016-2021 ($ millions) Global pacemaker electrodes market: Year-over-year growth 2017-2021 (%) TENS electrodes TENS is used in pain relief therapies.

  • Medical Equipment
  • Neurological Disorder
  • World
  • Forecast
  • Medtronic, Inc.
  • 7.2.2 BOSTON SCIENTIFIC - NEUROMODULATION PRODUCTS PORTFOLIO
  • 7.3.2 ST. JUDE MEDICAL - NEUROMODULATION PRODUCTS PORTFOLIO

The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are life changing....

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • DATE

Summary The neuromodulation technology utilizes devices that bring about a change in nervous system either by stimulation or modulating brain activity. The treatment delivered by neuromodulation devices brings about life changing transformation in patients who fail to get better by traditional approaches. The opportunities to...

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • INCREASING RESEARCH STUDIES ON ELECTRICAL STIMULATION

THE DEVICE INHIBITS THE PAIN SIGNALS BEFORE THEY REACH THE BRAIN, THUS LEADING TO INDIVIDUALS EXPERIENCING PAIN RELIEF.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

IT OFFERS PAIN RELIEF AND ANTI-INFLAMMATORY PROPERTIES.

  • Neurological Disorder
  • Allergan plc
  • Ipsen S.A.
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • 10. Market Growth Drivers

The system is designed to provide improved pain relief to individuals with chronic pain.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Nevro Corporation
  • SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)

Over the years, the global healthcare industry has witnessed a paradigm shift, and is now increasingly focused on minimally invasive therapies that not only treats a wide range of chronic and refractory disorders but also have fewer side effects. The demand for neuromodulation has increased significantly, because of patients’ preference for...

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • CHRONIC SHOULDER PAIN

TODAY, SPR (" STIMULATION FOR PAIN RELIEF" ) THERAPEUTICS OFFERS ITS LEAD PRODUCT, THE SMARTPATCH PNS SYSTEM, FOR CHRONIC POST-STROKE SHOULDER PAIN.

  • Neurological Disorder
  • United States
  • Bioness Inc.
  • Boston Scientific Corporation
  • Cyberonics, Inc.

The company provides pain relief therapies for low back pain and other types of chronic pain.

  • Clinical Trial
  • Health Care Provider
  • Neurological Disorder
  • Therapy
  • Nevro Corporation
  • Diabetic Peripheral Neuropathy - Product Development Milestones

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Neurological Disorder
  • Pathology
  • Therapy
  • United States
  • ViroMed Co., Ltd.

Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Grunenthal GmbH
  • SMALL MOLECULES TO ANTAGONIZE NMDA RECEPTOR AND CHRNA7 FOR CENTRAL NERVOUS SYSTEM - DRUG PROFILE

Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury.

  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • Grunenthal GmbH

However, these agents although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

  • Neurological Disorder
  • Neurology
  • Pharmaceutical
  • Therapy
  • Allergan plc
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY ARMAGEN INC, H2 2017
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Product Initiative

THE INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES AND TARGETED PAIN RELIEF, COUPLED WITH THE LIMITED SIDEEFFECTS AND COST-EFFECTIVE PAIN RELIEF OFFERED BY NEUROSTIMULATORS ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT.

  • Cardiac Management
  • Cardiovascular Disease
  • Medical Device
  • Medical Equipment
  • Neurological Disorder

However, these agents although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

  • Chronic Pain
  • Neurological Disorder
  • United States
  • Product Initiative
  • Allergan plc
  • cGMP manufacturing activities will be conducted at Catalent's primary softgel development and manufacturing facility in St. Petersburg, Florida.

It was under development for fibromyalgia, peripheral neuropathic pain.

  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • Neurocrine Biosciences, Inc.
  • Clinical Trial profile. 29 Trial Title
  • Clinical Trial Profile Snapshots

Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Complex Regional Pain Syndrome clinical trials scenario. This report provides top line data relating to the...

  • Neurological Disorder
  • Neurology
  • Therapy
  • World
  • Product Initiative
  • Target

Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016" provides an overview of Trigeminal Neuralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Trigeminal...

  • Health Services
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • PIPELINE BY BRISTOL-MYERS SQUIBB CO, H1 2018

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Neurological Disorder
  • Therapy
  • United States
  • World
  • Product Initiative
  • Diabetic Peripheral Neuropathy - Product Development Milestones

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Chronic Pain
  • Neurological Disorder
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.

Pain Relief after ## Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients with Post-stroke Lower Limb Spasticity RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke (

  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • Ipsen S.A.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

COMPLEX REGIONAL PAIN SYNDROME THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN G## COUNTRIES COMPLEX REGIONAL PAIN SYNDROME THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* COMPLEX REGIONAL PAIN SYNDROME THERAPEUTICS, G## CO

  • Drug Discovery And Development
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • HB-086 - DRUG PROFILE

Existing drugs provide a degree of pain relief.

  • Neurological Disorder
  • Research And Development
  • Company
  • Product Initiative
  • Can-Fite BioPharma Ltd.